Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China New Enterprise Invests Additional $25 Million in Shanghai Fudan-Zhangjiang

publication date: Nov 7, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China New Enterprise Investment, a growth capital firm, will invest $25.4 million to buy additional shares in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical. CNEI is said to have invested $20 million SFZJ earlier this year and owned 14% of the company’s Hong Kong-listed and domestic shares before the latest investment. SFZJ is an innovative drug company that listed on the Hong Kong Growth Enterprise Market in 2002.  More details....

Stock Symbol: (HK: 8231)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...